Figure 5.

In vitro motility inhibition by MTT reduction assay as a function of B. racemosa extract and fractions exposure (F1: crude ethanolic extract; F2: n-hexane fraction; F3: chloroform fraction; F4: n-butanol fraction).

In vitro motility inhibition by MTT reduction assay as a function of B. racemosa extract and fractions exposure (F1: crude ethanolic extract; F2: n-hexane fraction; F3: chloroform fraction; F4: n-butanol fraction).